We are doing our part to make health care more accessible during this pandemic. We are offering tele health, home and office visits as well as COVID testing to nonmembers in our community.
Symptomatic patients must be seen by tele health prior to testing.
Rapid PCR test results will be reported to the state and can be used for travel and school testing. We can provide an invoice to submit to your insurance.
PCR tests that are sent to a local lab and your insurance can be submitted at the time of testing.
We can not guarantee any testing is covered by insurance. The typical cost of COVID PCR testing at local labs is around $110.
Nasal swab PCR done in office with turnaround times of 30-60 minutes
Rapid COVID PCR/NAAT
Nasal swab PCR in pooled sample for 5 individuals.
If positive, individual tests must be performed.
Pooled Nonmembers $250
Pooled Members $200
PCR/NAAT sent to outside laboratory
Nasal swab PCR sent to local lab with turnaround times of 1-3 days
Provide insurance information if you would like it to be submitted through the outside lab. Cash price billed through lab = $110.
COVID 19 PCR testing requirements (links)
Frequently Asked Questions
What device is used in your office?
What is PCR test and how does it work?
The Accula SARS-CoV-2 RT-PCR test uses polymerase chain reaction (PCR) and lateral flow techniques for the detection of SARS-CoV-2 viral particles. It is also referred to as a nucleic acid amplification technique (NAAT) reflecting the part of the test that makes copies of the DNA that is then visually detected by lateral flow techniques.
There are 4 steps in the process:
1. Lysis of the virus
2. Reverse transcription (RT) of viral RNA to cDNA
3. Nucleic acid amplification by thermocycling polymerase chain reaction (PCR)
Is the Accula SARS-CoV-2 test FDA approved?
No. This test is available under FDA Emergency Use Authorization (EUA).
How accurate is the Accula SARS-CoV-2 Test?
Test accuracy is measured by percentage agreement with a reference method. In a prospective clinical validation study, the Accula SARS-CoV-2 Test achieved 100% positive and negative percent agreement (PPA and NPA) with an EUA-authorized RT-PCR SARS-CoV-2 test. In other words, every subject who tested positive according to the comparator test also tested positive according to the Accula SARS-CoV-2 Test, and the same for subjects who tested negative.
Data reported by the FDA on a variety of NAATs showed that the limit of detection (LoD) of the Accula SARS-CoV-2 Test is comparable to the best lab-based RT-PCR test and far more sensitive than all other rapid methods tested.
Is rapid ANTIGEN testing or PCR testing more accurate?
Rapid antigen testing is most accurate when a patient is symptomatic. It is detecting SARS-CoV-2 antigen. This is the type of test that is available over the counter. PCR testing is more accurate for symptomatic and asymptomatic patients because it is testing for the genetic material (in this case RNA). The amplification technique helps to detect virus at a much lower level. Consider this CDC reference comparing antigen testing to PCR showing antigen testing sensitivity of 92.6% and 78.6% for symptomatic and asymptomatic individuals, respectively.
Will the accuracy of this test be affected by new variants such as Omicron?
There is a possibility that the test could be affected by variants but the impact doesn't appear to be significant. The FDA mentions this out of abundance of caution but it doesn't appear to be enough to discount this test.